Drug
Mabthera
Mabthera: highest development phase Phase 1, developed by Gedeon Richter. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Gedeon Richter
Trials
| Drug | Phase | Indication |
|---|---|---|
| MabThera (rituximab) NCT02371096 | Phase 1 | Rheumatoid Arthritis |
Latest
No recent events.
Follow Mabthera on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.